| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9017316 | Pulmonary Pharmacology & Therapeutics | 2005 | 4 Pages |
Abstract
Trans sodium crocetinate is a novel drug, which has been shown previously to increase whole-body oxygen consumption during hemorrhagic shock. TSC has been suggested to work by increasing the diffusion rate of oxygen through plasma rather than on a specific symptom of hemorrhagic shock and has been suggested as a general treatment for hypoxemia. Thus, it might also be beneficial for treating respiratory insufficiencies. This study employed an oleic acid model of acute lung injury to determine if TSC could increase arterial PO2 in that model.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
J.L. Gainer, A.K. Stennett, R.J. Murray,